List of Locoid drug patents
Locoid is owned by Bausch.
Locoid contains Hydrocortisone Butyrate.
Locoid has a total of 2 drug patents out of which 0 drug patents have expired.
Locoid was authorised for market use on 18 May, 2007.
Locoid is available in lotion;topical dosage forms.
The generics of Locoid are possible to be released after 19 December, 2026.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7981877 | BAUSCH | Stabilized steroid composition and method for its preparation |
Jan, 2025
(1 year, 7 months from now) | |
| US7378405 | BAUSCH | Stabilized steroid composition and method for its preparation |
Dec, 2026
(3 years from now) | |
Do you want to check out LOCOID patents from before 2022?
Drugs and Companies using HYDROCORTISONE BUTYRATE ingredient
Market Authorisation Date: 18 May, 2007
Treatment: NA
Dosage: LOTION;TOPICAL
How can I launch a generic of LOCOID before it's patent expiration?
More Information on Dosage
LOCOID family patents
5
United States
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic